Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Adoptive Cell Therapy Revenue 1.4 Market Analysis by Type 1.4.1 Global Adoptive Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 CAR-T 1.4.3 TCR-T 1.4.4 NK 1.4.5 TIL 1.5 Market by Application 1.5.1 Global Adoptive Cell Therapy Market Share by Application: 2020 VS 2026 1.5.2 Lymphoma 1.5.3 Leukemia 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Adoptive Cell Therapy Market Perspective (2015-2026) 2.2 Adoptive Cell Therapy Growth Trends by Regions 2.2.1 Adoptive Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Adoptive Cell Therapy Historic Market Share by Regions (2015-2020) 2.2.3 Adoptive Cell Therapy Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Adoptive Cell Therapy Market Growth Strategy 2.3.6 Primary Interviews with Key Adoptive Cell Therapy Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Adoptive Cell Therapy Players by Market Size 3.1.1 Global Top Adoptive Cell Therapy Players by Revenue (2015-2020) 3.1.2 Global Adoptive Cell Therapy Revenue Market Share by Players (2015-2020) 3.1.3 Global Adoptive Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Adoptive Cell Therapy Market Concentration Ratio 3.2.1 Global Adoptive Cell Therapy Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Adoptive Cell Therapy Revenue in 2019 3.3 Adoptive Cell Therapy Key Players Head office and Area Served 3.4 Key Players Adoptive Cell Therapy Product Solution and Service 3.5 Date of Enter into Adoptive Cell Therapy Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Adoptive Cell Therapy Historic Market Size by Type (2015-2020) 4.2 Global Adoptive Cell Therapy Forecasted Market Size by Type (2021-2026) 5 Adoptive Cell Therapy Breakdown Data by Application (2015-2026) 5.1 Global Adoptive Cell Therapy Market Size by Application (2015-2020) 5.2 Global Adoptive Cell Therapy Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Adoptive Cell Therapy Market Size (2015-2020) 6.2 Adoptive Cell Therapy Key Players in North America (2019-2020) 6.3 North America Adoptive Cell Therapy Market Size by Type (2015-2020) 6.4 North America Adoptive Cell Therapy Market Size by Application (2015-2020) 7 Europe 7.1 Europe Adoptive Cell Therapy Market Size (2015-2020) 7.2 Adoptive Cell Therapy Key Players in Europe (2019-2020) 7.3 Europe Adoptive Cell Therapy Market Size by Type (2015-2020) 7.4 Europe Adoptive Cell Therapy Market Size by Application (2015-2020) 8 China 8.1 China Adoptive Cell Therapy Market Size (2015-2020) 8.2 Adoptive Cell Therapy Key Players in China (2019-2020) 8.3 China Adoptive Cell Therapy Market Size by Type (2015-2020) 8.4 China Adoptive Cell Therapy Market Size by Application (2015-2020) 9 Japan 9.1 Japan Adoptive Cell Therapy Market Size (2015-2020) 9.2 Adoptive Cell Therapy Key Players in Japan (2019-2020) 9.3 Japan Adoptive Cell Therapy Market Size by Type (2015-2020) 9.4 Japan Adoptive Cell Therapy Market Size by Application (2015-2020) 10 South Korea 10.1 South Korea Adoptive Cell Therapy Market Size (2015-2020) 10.2 Adoptive Cell Therapy Key Players in South Korea (2019-2020) 10.3 South Korea Adoptive Cell Therapy Market Size by Type (2015-2020) 10.4 South Korea Adoptive Cell Therapy Market Size by Application (2015-2020) 11 India 11.1 India Adoptive Cell Therapy Market Size (2015-2020) 11.2 Adoptive Cell Therapy Key Players in India (2019-2020) 11.3 India Adoptive Cell Therapy Market Size by Type (2015-2020) 11.4 India Adoptive Cell Therapy Market Size by Application (2015-2020) 12 Key Players Profiles 12.1 Novartis 12.1.1 Novartis Company Details 12.1.2 Novartis Business Overview and Its Total Revenue 12.1.3 Novartis Adoptive Cell Therapy Introduction 12.1.4 Novartis Revenue in Adoptive Cell Therapy Business (2015-2020)) 12.1.5 Novartis Recent Development 12.2 Juno 12.2.1 Juno Company Details 12.2.2 Juno Business Overview and Its Total Revenue 12.2.3 Juno Adoptive Cell Therapy Introduction 12.2.4 Juno Revenue in Adoptive Cell Therapy Business (2015-2020) 12.2.5 Juno Recent Development 12.3 Kite 12.3.1 Kite Company Details 12.3.2 Kite Business Overview and Its Total Revenue 12.3.3 Kite Adoptive Cell Therapy Introduction 12.3.4 Kite Revenue in Adoptive Cell Therapy Business (2015-2020) 12.3.5 Kite Recent Development 12.4 Adaptimmune 12.4.1 Adaptimmune Company Details 12.4.2 Adaptimmune Business Overview and Its Total Revenue 12.4.3 Adaptimmune Adoptive Cell Therapy Introduction 12.4.4 Adaptimmune Revenue in Adoptive Cell Therapy Business (2015-2020) 12.4.5 Adaptimmune Recent Development 12.5 Fibrocell 12.5.1 Fibrocell Company Details 12.5.2 Fibrocell Business Overview and Its Total Revenue 12.5.3 Fibrocell Adoptive Cell Therapy Introduction 12.5.4 Fibrocell Revenue in Adoptive Cell Therapy Business (2015-2020) 12.5.5 Fibrocell Recent Development 12.6 Lineage Cell Therapeutics 12.6.1 Lineage Cell Therapeutics Company Details 12.6.2 Lineage Cell Therapeutics Business Overview and Its Total Revenue 12.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Introduction 12.6.4 Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2015-2020) 12.6.5 Lineage Cell Therapeutics Recent Development 12.7 BioTime 12.7.1 BioTime Company Details 12.7.2 BioTime Business Overview and Its Total Revenue 12.7.3 BioTime Adoptive Cell Therapy Introduction 12.7.4 BioTime Revenue in Adoptive Cell Therapy Business (2015-2020) 12.7.5 BioTime Recent Development 12.8 Vericel Corporation 12.8.1 Vericel Corporation Company Details 12.8.2 Vericel Corporation Business Overview and Its Total Revenue 12.8.3 Vericel Corporation Adoptive Cell Therapy Introduction 12.8.4 Vericel Corporation Revenue in Adoptive Cell Therapy Business (2015-2020) 12.8.5 Vericel Corporation Recent Development 12.9 Regeneus 12.9.1 Regeneus Company Details 12.9.2 Regeneus Business Overview and Its Total Revenue 12.9.3 Regeneus Adoptive Cell Therapy Introduction 12.9.4 Regeneus Revenue in Adoptive Cell Therapy Business (2015-2020) 12.9.5 Regeneus Recent Development 12.10 Anhui Anke Biotechnology 12.10.1 Anhui Anke Biotechnology Company Details 12.10.2 Anhui Anke Biotechnology Business Overview and Its Total Revenue 12.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Introduction 12.10.4 Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2015-2020) 12.10.5 Anhui Anke Biotechnology Recent Development 12.11 Cellectis 10.11.1 Cellectis Company Details 10.11.2 Cellectis Business Overview and Its Total Revenue 10.11.3 Cellectis Adoptive Cell Therapy Introduction 10.11.4 Cellectis Revenue in Adoptive Cell Therapy Business (2015-2020) 10.11.5 Cellectis Recent Development 12.12 NantKwest 10.12.1 NantKwest Company Details 10.12.2 NantKwest Business Overview and Its Total Revenue 10.12.3 NantKwest Adoptive Cell Therapy Introduction 10.12.4 NantKwest Revenue in Adoptive Cell Therapy Business (2015-2020) 10.12.5 NantKwest Recent Development 12.13 SorrentoTherapeutics 10.13.1 SorrentoTherapeutics Company Details 10.13.2 SorrentoTherapeutics Business Overview and Its Total Revenue 10.13.3 SorrentoTherapeutics Adoptive Cell Therapy Introduction 10.13.4 SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2015-2020) 10.13.5 SorrentoTherapeutics Recent Development 12.14 Bellicum 10.14.1 Bellicum Company Details 10.14.2 Bellicum Business Overview and Its Total Revenue 10.14.3 Bellicum Adoptive Cell Therapy Introduction 10.14.4 Bellicum Revenue in Adoptive Cell Therapy Business (2015-2020) 10.14.5 Bellicum Recent Development 13 Analyst's Viewpoints/Conclusions 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Disclaimer 14.3 Author Details

List of Tables Table 1. Adoptive Cell Therapy Key Market Segments Table 2. Key Players Covered: Ranking by Adoptive Cell Therapy Revenue Table 3. Ranking of Global Top Adoptive Cell Therapy Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Adoptive Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of CAR-T Table 6. Key Players of TCR-T Table 7. Key Players of NK Table 8. Key Players of TIL Table 9. Global Adoptive Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global Adoptive Cell Therapy Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global Adoptive Cell Therapy Market Size by Regions (2015-2020) (US$ Million) Table 12. Global Adoptive Cell Therapy Market Share by Regions (2015-2020) Table 13. Global Adoptive Cell Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global Adoptive Cell Therapy Market Share by Regions (2021-2026) Table 15. Market Top Trends Table 16. Key Drivers: Impact Analysis Table 17. Key Challenges Table 18. Adoptive Cell Therapy Market Growth Strategy Table 19. Main Points Interviewed from Key Adoptive Cell Therapy Players Table 20. Global Adoptive Cell Therapy Revenue by Players (2015-2020) (Million US$) Table 21. Global Adoptive Cell Therapy Market Share by Players (2015-2020) Table 22. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cell Therapy as of 2019) Table 23. Global Adoptive Cell Therapy by Players Market Concentration Ratio (CR5 and HHI) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Adoptive Cell Therapy Product Solution and Service Table 26. Date of Enter into Adoptive Cell Therapy Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$) Table 29. Global Adoptive Cell Therapy Market Size Share by Type (2015-2020) Table 30. Global Adoptive Cell Therapy Revenue Market Share by Type (2021-2026) Table 31. Global Adoptive Cell Therapy Market Size Share by Application (2015-2020) Table 32. Global Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$) Table 33. Global Adoptive Cell Therapy Market Size Share by Application (2021-2026) Table 34. North America Key Players Adoptive Cell Therapy Revenue (2019-2020) (Million US$) Table 35. North America Key Players Adoptive Cell Therapy Market Share (2019-2020) Table 36. North America Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$) Table 37. North America Adoptive Cell Therapy Market Share by Type (2015-2020) Table 38. North America Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$) Table 39. North America Adoptive Cell Therapy Market Share by Application (2015-2020) Table 40. Europe Key Players Adoptive Cell Therapy Revenue (2019-2020) (Million US$) Table 41. Europe Key Players Adoptive Cell Therapy Market Share (2019-2020) Table 42. Europe Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$) Table 43. Europe Adoptive Cell Therapy Market Share by Type (2015-2020) Table 44. Europe Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$) Table 45. Europe Adoptive Cell Therapy Market Share by Application (2015-2020) Table 46. China Key Players Adoptive Cell Therapy Revenue (2019-2020) (Million US$) Table 47. China Key Players Adoptive Cell Therapy Market Share (2019-2020) Table 48. China Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$) Table 49. China Adoptive Cell Therapy Market Share by Type (2015-2020) Table 50. China Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$) Table 51. China Adoptive Cell Therapy Market Share by Application (2015-2020) Table 52. Japan Key Players Adoptive Cell Therapy Revenue (2019-2020) (Million US$) Table 53. Japan Key Players Adoptive Cell Therapy Market Share (2019-2020) Table 54. Japan Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$) Table 55. Japan Adoptive Cell Therapy Market Share by Type (2015-2020) Table 56. Japan Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$) Table 57. Japan Adoptive Cell Therapy Market Share by Application (2015-2020) Table 58. South Korea Key Players Adoptive Cell Therapy Revenue (2019-2020) (Million US$) Table 59. South Korea Key Players Adoptive Cell Therapy Market Share (2019-2020) Table 60. South Korea Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$) Table 61. South Korea Adoptive Cell Therapy Market Share by Type (2015-2020) Table 62. South Korea Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$) Table 63. South Korea Adoptive Cell Therapy Market Share by Application (2015-2020) Table 64. India Key Players Adoptive Cell Therapy Revenue (2019-2020) (Million US$) Table 65. India Key Players Adoptive Cell Therapy Market Share (2019-2020) Table 66. India Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$) Table 67. India Adoptive Cell Therapy Market Share by Type (2015-2020) Table 68. India Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$) Table 69. India Adoptive Cell Therapy Market Share by Application (2015-2020) Table 70. Novartis Company Details Table 71. Novartis Business Overview Table 72. Novartis Product Table 73. Novartis Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$) Table 74. Novartis Recent Development Table 75. Juno Company Details Table 76. Juno Business Overview Table 77. Juno Product Table 78. Juno Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$) Table 79. Juno Recent Development Table 80. Kite Company Details Table 81. Kite Business Overview Table 82. Kite Product Table 83. Kite Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$) Table 84. Kite Recent Development Table 85. Adaptimmune Company Details Table 86. Adaptimmune Business Overview Table 87. Adaptimmune Product Table 88. Adaptimmune Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$) Table 89. Adaptimmune Recent Development Table 90. Fibrocell Company Details Table 91. Fibrocell Business Overview Table 92. Fibrocell Product Table 93. Fibrocell Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$) Table 94. Fibrocell Recent Development Table 95. Lineage Cell Therapeutics Company Details Table 96. Lineage Cell Therapeutics Business Overview Table 97. Lineage Cell Therapeutics Product Table 98. Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$) Table 99. Lineage Cell Therapeutics Recent Development Table 100. BioTime Company Details Table 101. BioTime Business Overview Table 102. BioTime Product Table 103. BioTime Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$) Table 104. BioTime Recent Development Table 105. Vericel Corporation Business Overview Table 106. Vericel Corporation Product Table 107. Vericel Corporation Company Details Table 108. Vericel Corporation Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$) Table 109. Vericel Corporation Recent Development Table 110. Regeneus Company Details Table 111. Regeneus Business Overview Table 112. Regeneus Product Table 113. Regeneus Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$) Table 114. Regeneus Recent Development Table 115. Anhui Anke Biotechnology Company Details Table 116. Anhui Anke Biotechnology Business Overview Table 117. Anhui Anke Biotechnology Product Table 118. Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$) Table 119. Anhui Anke Biotechnology Recent Development Table 120. Cellectis Company Details Table 121. Cellectis Business Overview Table 122. Cellectis Product Table 123. Cellectis Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$) Table 124. Cellectis Recent Development Table 125. NantKwest Company Details Table 126. NantKwest Business Overview Table 127. NantKwest Product Table 128. NantKwest Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$) Table 129. NantKwest Recent Development Table 130. SorrentoTherapeutics Company Details Table 131. SorrentoTherapeutics Business Overview Table 132. SorrentoTherapeutics Product Table 133. SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$) Table 134. SorrentoTherapeutics Recent Development Table 135. Bellicum Company Details Table 136. Bellicum Business Overview Table 137. Bellicum Product Table 138. Bellicum Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$) Table 139. Bellicum Recent Development Table 140. Research Programs/Design for This Report Table 141. Key Data Information from Secondary Sources Table 142. Key Data Information from Primary Sources List of Figures Figure 1. Global Adoptive Cell Therapy Market Share by Type: 2020 VS 2026 Figure 2. CAR-T Features Figure 3. TCR-T Features Figure 4. NK Features Figure 5. TIL Features Figure 6. Global Adoptive Cell Therapy Market Share by Application: 2020 VS 2026 Figure 7. Lymphoma Case Studies Figure 8. Leukemia Case Studies Figure 9. Adoptive Cell Therapy Report Years Considered Figure 10. Global Adoptive Cell Therapy Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Adoptive Cell Therapy Market Share by Regions: 2020 VS 2026 Figure 12. Global Adoptive Cell Therapy Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Adoptive Cell Therapy Market Share by Players in 2019 Figure 15. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cell Therapy as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Adoptive Cell Therapy Revenue in 2019 Figure 17. North America Adoptive Cell Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Adoptive Cell Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Adoptive Cell Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Adoptive Cell Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 21. South Korea Adoptive Cell Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Adoptive Cell Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Novartis Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020) Figure 25. Juno Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Juno Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020) Figure 27. Kite Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Kite Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020) Figure 29. Adaptimmune Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Adaptimmune Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020) Figure 31. Fibrocell Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Fibrocell Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020) Figure 33. Lineage Cell Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Lineage Cell Therapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020) Figure 35. BioTime Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. BioTime Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020) Figure 37. Vericel Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Vericel Corporation Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020) Figure 39. Regeneus Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Regeneus Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020) Figure 41. Anhui Anke Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Anhui Anke Biotechnology Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020) Figure 43. Cellectis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Cellectis Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020) Figure 45. NantKwest Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. NantKwest Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020) Figure 47. SorrentoTherapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. SorrentoTherapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020) Figure 49. Bellicum Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Bellicum Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020) Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Novartis Juno Kite Adaptimmune Fibrocell Lineage Cell Therapeutics BioTime Vericel Corporation Regeneus Anhui Anke Biotechnology Cellectis NantKwest SorrentoTherapeutics Bellicum